Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Shigeo_Taniuchi
|
| gptkbp:founded |
1890
|
| gptkbp:founder |
gptkb:Kenkichi_Taguchi
|
| gptkbp:headquartersLocation |
gptkb:Osaka,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
Santen
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:listedOn |
gptkb:Nikkei_225
|
| gptkbp:notableProduct |
gptkb:Diquas
gptkb:Tapros gptkb:Eylea gptkb:Ikervis |
| gptkbp:numberOfEmployees |
over 4000
|
| gptkbp:revenue |
over 250 billion yen (2023)
|
| gptkbp:servesArea |
worldwide
|
| gptkbp:specializesIn |
ophthalmology
|
| gptkbp:stockExchange |
gptkb:Tokyo_Stock_Exchange
|
| gptkbp:stockSymbol |
4536
|
| gptkbp:subsidiary |
gptkb:Santen_Inc._(USA)
gptkb:Santen_Pharmaceutical_(China)_Co.,_Ltd. |
| gptkbp:website |
https://www.santen.com/
|
| gptkbp:bfsParent |
gptkb:M-Files
|
| gptkbp:bfsLayer |
5
|